EHRA White Paper: knowledge gaps in arrhythmia management-status 2019.
暂无分享,去创建一个
A. Camm | I. V. Van Gelder | G. Hindricks | A. Goette | S. Hohnloser | G. Boriani | L. Fauchier | J. Svendsen | C. Leclercq | F. Prinzen | H. Crijns | K. Zeppenfeld | J. Merino | J. Deharo | M. Brignole | H. Burri | F. Braunschweig | R. Schilling | H. Heidbüchel | A. Proclemer | A. Auricchio | S. Boveda | D. Dobrev | N. Dagres | G. Lip | L. Mont | T. Lewalter | R. Hatala | I. Savelieva | H. Pürerfellner | F. Heinzel | P. Defaye | J. B. Terradellas | J. Steffel | I. Zupan | V. Traykov | J. G. Guerra Ramos | A. Camm | Stefan H Hohnloser | Gregory Y H Lip | Jose Luis Merino | Jongi Chun | G. Lip | European Heart Rhythm | Association White Paper | Arrhythmia Fibrillation | Tachycardia Heart | A. W. Paper
[1] A. Goette,et al. Clinical importance of atrial cardiomyopathy. , 2019, International journal of cardiology.
[2] D. Dobrev,et al. Role of inflammatory signaling in atrial fibrillation. , 2019, International journal of cardiology.
[3] P. Libby,et al. Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure , 2019, Circulation.
[4] A. Goette,et al. Impact of dronedarone on the risk of myocardial infarction and stroke in atrial fibrillation patients followed in general practices in Germany. , 2019, International journal of cardiology.
[5] G. Lip,et al. Spontaneous conversion in patients with non‐valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE‐AF) trial , 2019, American heart journal.
[6] S. Nattel,et al. Postoperative atrial fibrillation: mechanisms, manifestations and management , 2019, Nature Reviews Cardiology.
[7] E. Braunwald,et al. Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure , 2019, The New England journal of medicine.
[8] X. Wehrens,et al. Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector , 2019, Circulation research.
[9] Asif Ahmed,et al. Survival after cardiac resynchronization therapy: results from 50 084 implantations , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[10] Corey L. Reynolds,et al. Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation , 2018, Circulation.
[11] P. Lambiase,et al. Temporal pattern/episode duration-based classification of atrial fibrillation as paroxysmal vs. persistent: is it time to develop a more integrated prognostic score to optimize management? , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[12] K. Ellenbogen,et al. Permanent His-bundle pacing: a systematic literature review and meta-analysis , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[13] A. Goette,et al. German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management , 2018, Clinical Research in Cardiology.
[14] R. Hawkins,et al. Postoperative atrial fibrillation is associated with increased morbidity and resource utilization after left ventricular assist device placement , 2018, Journal of Thoracic and Cardiovascular Surgery.
[15] Michael J Ackerman,et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2018, Journal of the American College of Cardiology.
[16] G. Boriani,et al. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter‐defibrillator therapies and hospitalizations , 2018, European journal of heart failure.
[17] D. Dobrev,et al. Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging , 2018, International journal of cardiology. Heart & vasculature.
[18] C. Torp‐Pedersen,et al. Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study , 2018, Europace.
[19] F. Crea,et al. Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy–defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[20] P. Lambiase,et al. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[21] M. Brignole,et al. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS , 2018, European heart journal.
[22] K. Ellenbogen,et al. Long-term outcomes of His bundle pacing in patients with heart failure with left bundle branch block , 2018, Heart.
[23] Jennifer Cook Middleton,et al. Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force , 2018, JAMA.
[24] A. Camm,et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary. , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[25] W. Stevenson,et al. Management of Ventricular Arrhythmias and Sudden Cardiac Death Risk Associated With Cardiac Channelopathies. , 2018, JAMA cardiology.
[26] J. Healey,et al. Cardiac resynchronization is pro-arrhythmic in the absence of reverse ventricular remodelling: a systematic review and meta-analysis , 2018, Cardiovascular research.
[27] S. Steinhubl,et al. Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial , 2018, JAMA.
[28] A. Goette,et al. Integration of “omics” techniques: Dronedarone affects cardiac remodeling in the infarction border zone , 2018, Experimental biology and medicine.
[29] G. Boriani,et al. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries endorsed by APHRS/HRS/LAHRS , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[30] G. Hindricks,et al. Cardiac resynchronization therapy in the ageing population - With or without an implantable defibrillator? , 2018, International journal of cardiology.
[31] G. Hindricks,et al. Cardiac resynchronization therapy in heart failure: is the defibrillator needed? , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[32] K. Dickstein,et al. Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II , 2018, European journal of heart failure.
[33] G. Doros,et al. Features of atrial fibrillation in wild‐type transthyretin cardiac amyloidosis: a systematic review and clinical experience , 2018, ESC Heart Failure.
[34] D. Scherr,et al. Management of patients with ventricular arrhythmias and prevention of sudden cardiac death—translating guidelines into practice: results of the European Heart Rhythm Association survey , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[35] G. Dandamudi,et al. Clinical Outcomes of His Bundle Pacing Compared to Right Ventricular Pacing. , 2018, Journal of the American College of Cardiology.
[36] J. Hummel,et al. Leadless pacemaker implantation and concurrent atrioventricular junction ablation in patients with atrial fibrillation , 2018, Pacing and clinical electrophysiology : PACE.
[37] A. Capucci,et al. Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective survey , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[38] R. Tieleman,et al. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE) , 2018 .
[39] M. Masuda,et al. Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation. , 2018, International journal of cardiology.
[40] G. Boriani,et al. Clinically oriented device programming in bradycardia patients: part 2 (atrioventricular blocks and neurally mediated syncope). Proposals from AIAC (Italian Association of Arrhythmology and Cardiac Pacing) , 2018, Journal of cardiovascular medicine.
[41] G. Boriani,et al. Clinically oriented device programming in bradycardia patients: part 1 (sinus node disease). Proposals from AIAC (Italian Association of Arrhythmology and Cardiac Pacing) , 2018, Journal of cardiovascular medicine.
[42] S. Nattel,et al. Translational Challenges in Atrial Fibrillation , 2018, Circulation research.
[43] E. Schwammenthal,et al. Rationale and design of the EACVI AFib Echo Europe Registry for assessing relationships of echocardiographic parameters with clinical thrombo-embolic and bleeding risk profile in non-valvular atrial fibrillation. , 2018, European heart journal cardiovascular Imaging.
[44] Yuehua Liu,et al. Elevated Circulating Fibrocytes Is a Marker of Left Atrial Fibrosis and Recurrence of Persistent Atrial Fibrillation , 2018, Journal of the American Heart Association.
[45] M. Dorobanțu,et al. The role of pro‐fibrotic biomarkers in paroxysmal and persistent atrial fibrillation , 2018, Cytokine.
[46] G. Breithardt,et al. Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[47] R. Borrás,et al. Multielectrode vs. point-by-point mapping for ventricular tachycardia substrate ablation: a randomized study , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[48] Christopher R. Ellis,et al. Prospective Randomized Evaluation of Implantable Cardioverter‐Defibrillator Programming in Patients With a Left Ventricular Assist Device , 2018, Journal of the American Heart Association.
[49] D. Lin,et al. Reversal of Pacing-Induced Cardiomyopathy Following Cardiac Resynchronization Therapy. , 2018, JACC. Clinical electrophysiology.
[50] L. Jordaens,et al. Catheter Ablation for Atrial Fibrillation with Heart Failure , 2018, The New England journal of medicine.
[51] G. Lip,et al. Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study). , 2018, The American journal of cardiology.
[52] Dhanunjaya R. Lakkireddy,et al. Hemodynamic Support in Ventricular Tachycardia Ablation: An International VT Ablation Center Collaborative Group Study. , 2017, JACC. Clinical electrophysiology.
[53] V. Jeevanandam,et al. Characterization of Ventricular Tachycardia After Left Ventricular Assist Device Implantation as Destination Therapy: A Single-Center Ablation Experience. , 2017, JACC. Clinical electrophysiology.
[54] P. Vijayaraman,et al. Atrioventricular node ablation and His bundle pacing. , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[55] D. Mancini,et al. Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist Device: An Analysis of the INTERMACS Registry. , 2017, JACC. Heart failure.
[56] H. Huikuri,et al. Association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease. , 2017, International journal of cardiology.
[57] M. Shoda,et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. , 2017, Heart rhythm.
[58] Y. Chun,et al. Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry , 2017, Chest.
[59] D. Fitzmaurice,et al. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation , 2017, BMJ Open.
[60] P. García-Pavía,et al. Diagnóstico y tratamiento de la amiloidosis cardiaca por transtiretina. Progreso y esperanza. , 2017 .
[61] S. Yusuf,et al. A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score , 2017, European heart journal.
[62] B. Merkely,et al. De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis , 2017, Heart Failure Reviews.
[63] K. Ellenbogen,et al. Permanent His-bundle pacing as an alternative to biventricular pacing for cardiac resynchronization therapy: A multicenter experience. , 2017, Heart rhythm.
[64] G. Boriani,et al. Atrial antitachycardia pacing and atrial remodeling: A substudy of the international, randomized MINERVA trial. , 2017, Heart rhythm.
[65] M. Chung,et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[66] G. Lip,et al. Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Elect , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[67] B. Wilkoff,et al. Compliant endovascular balloon reduces the lethality of superior vena cava tears during transvenous lead extractions. , 2017, Heart rhythm.
[68] M. Haissaguerre,et al. Electrical storm in the early phase of HeartMate® II device implantation: Incidence, risk factors and prognosis. , 2017, Archives of cardiovascular diseases.
[69] A. Goette,et al. CREM-transgene mice: An animal model of atrial fibrillation and thrombogenesis. , 2017, Thrombosis research.
[70] S. Narayan,et al. Spatial relationship of organized rotational and focal sources in human atrial fibrillation to autonomic ganglionated plexi. , 2017, International journal of cardiology.
[71] Gerhard Hindricks,et al. A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[72] B. Norrving,et al. Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study , 2017, PloS one.
[73] G. Hindricks,et al. Devices for management of sudden cardiac death: Successes, challenges and perspectives. , 2017, International Journal of Cardiology.
[74] A. Adler,et al. Mechanical Support With Impella During Malignant Arrhythmia Ablation: A Case Report on the Growing Trend in the Electrophysiology Laboratory. , 2017, A & A case reports.
[75] Charles R Kerr,et al. Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation. , 2017, Heart rhythm.
[76] G. Boriani,et al. 1315Effectiveness of a reactive atrial antitachycardia pacing feature in patients with ICDs: A large database analysis , 2017 .
[77] J. Goldberger,et al. Sudden Cardiac Arrest Risk Assessment: Population Science and the Individual Risk Mandate , 2017, JAMA cardiology.
[78] V. Reddy,et al. Outcomes of Ventricular Tachycardia Ablation Using Percutaneous Left Ventricular Assist Devices , 2017, Circulation. Arrhythmia and electrophysiology.
[79] D. Pennell,et al. Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction , 2017 .
[80] J. Morgan,et al. Remote management of heart failure using implantable electronic devices , 2017, European heart journal.
[81] G. Hindricks,et al. Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST) , 2017, European heart journal.
[82] P. Kirchhof,et al. Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration , 2017, Circulation.
[83] P. Neužil,et al. Cardiac Resynchronization Therapy With Wireless Left Ventricular Endocardial Pacing: The SELECT-LV Study. , 2017, Journal of the American College of Cardiology.
[84] S. Nattel,et al. Controversies About Atrial Fibrillation Mechanisms: Aiming for Order in Chaos and Whether it Matters , 2017, Circulation research.
[85] N. Verma,et al. Permanent His bundle pacing at the time of atrioventricular node ablation: A 3-dimensional mapping approach , 2017, HeartRhythm case reports.
[86] R. Tilz,et al. Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease—indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[87] K. Ellenbogen,et al. Benefits of Permanent His Bundle Pacing Combined With Atrioventricular Node Ablation in Atrial Fibrillation Patients With Heart Failure With Both Preserved and Reduced Left Ventricular Ejection Fraction , 2017, Journal of the American Heart Association.
[88] A. Auricchio,et al. Inappropriate shocks in single-chamber and subcutaneous implantable cardioverter-defibrillators: a systematic review and meta-analysis , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[89] A. Bouzeman,et al. Variability in obstructive sleep apnea: Analysis of pacemaker-detected respiratory disturbances. , 2017, Heart rhythm.
[90] P. Kowey,et al. Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter‐defibrillators: The SHIELD‐2 trial , 2017, American heart journal.
[91] M. Gold,et al. Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication. , 2017, Heart rhythm.
[92] Gene Kim,et al. Atrial Arrhythmias and Electroanatomical Remodeling in Patients With Left Ventricular Assist Devices , 2017, Journal of the American Heart Association.
[93] T. Weber,et al. Cardiac gene therapy with adeno-associated virus-based vectors , 2017, Current opinion in cardiology.
[94] J. Prutkin,et al. Simultaneous atrioventricular node ablation and leadless pacemaker implantation☆☆☆ , 2017, HeartRhythm case reports.
[95] B. Bettencourt,et al. A Highly Durable RNAi Therapeutic Inhibitor of PCSK9 , 2017, The New England journal of medicine.
[96] Angelo B. Biviano,et al. Atrial Fibrillation in Patients With Left Ventricular Assist Devices: Incidence, Predictors, and Clinical Outcomes. , 2016, JACC. Clinical electrophysiology.
[97] P. Sharma,et al. His Bundle Pacing Or Biventricular Pacing For Cardiac Resynchronization Therapy In Heart Failure: Discovering New Methods For An Old Problem. , 2016, Journal of atrial fibrillation.
[98] P. Lambiase,et al. Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation. , 2016, The Cochrane database of systematic reviews.
[99] P. Kirchhof,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[100] Abhishek Sharma,et al. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices - A meta-analysis. , 2016, International journal of cardiology.
[101] T. Rostock,et al. Cardiac arrhythmias in patients with Danon disease , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[102] A. Capucci,et al. Clinically guided pacemaker choice and setting: pacemaker expert programming study , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[103] P. Ponikowski,et al. [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.
[104] I. Goldenberg,et al. Morbidity and mortality with cardiac resynchronization therapy with pacing vs. with defibrillation in octogenarian patients in a real-world setting , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[105] S. Nattel,et al. Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation , 2016, Nature Reviews Cardiology.
[106] K. Kario,et al. Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation , 2016, Stroke.
[107] G. Lip,et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[108] S. Niwano,et al. Discrimination of Paroxysmal and Persistent Atrial Fibrillation in Patients With New-Onset Atrial Fibrillation. , 2016, International heart journal.
[109] C. Antzelevitch,et al. Atrial fibrillation in inherited cardiac channelopathies: From mechanisms to management. , 2016, Heart rhythm.
[110] Michela Masè,et al. Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis. , 2016, JACC. Cardiovascular imaging.
[111] C. Israel,et al. Optimal tachycardia programming in ICDs , 2016, Herzschrittmachertherapie + Elektrophysiologie.
[112] Hans Eiskjær,et al. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. , 2016, The New England journal of medicine.
[113] A. Proclemer,et al. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[114] Christophe Leclercq,et al. ALternate Site Cardiac ResYNChronization (ALSYNC): a prospective and multicentre study of left ventricular endocardial pacing for cardiac resynchronization therapy. , 2016, European heart journal.
[115] Hugh Calkins,et al. Catheter ablation in patients with persistent atrial fibrillation , 2016, European heart journal.
[116] Maxime Sermesant,et al. Impact of New Technologies and Approaches for Post–Myocardial Infarction Ventricular Tachycardia Ablation During Long-Term Follow-Up , 2016, Circulation. Arrhythmia and electrophysiology.
[117] A. Moss,et al. Sustained clinical benefit of cardiac resynchronization therapy in non-LBBB patients with prolonged PR-interval: MADIT-CRT long-term follow-up , 2016, Clinical Research in Cardiology.
[118] A. Curtis,et al. Improvement in Clinical Outcomes With Biventricular Versus Right Ventricular Pacing: The BLOCK HF Study. , 2016, Journal of the American College of Cardiology.
[119] John L Sapp,et al. Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. , 2016, The New England journal of medicine.
[120] S. Pocock,et al. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. , 2016, The New England journal of medicine.
[121] J. Brachmann,et al. German ablation registry: Cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation--One-year outcome data. , 2016, Heart rhythm.
[122] S. Nattel,et al. The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis. , 2016, Cardiovascular research.
[123] Ashok J. Shah,et al. Persistent Atrial Fibrillation From the Onset: A Specific Subgroup of Patients With Biatrial Substrate Involvement and Poorer Clinical Outcome. , 2016, JACC. Clinical electrophysiology.
[124] A. Moss,et al. Relationship between age and inappropriate implantable cardioverter-defibrillator therapy in MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy). , 2016, Heart rhythm.
[125] L. Friberg,et al. Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. , 2016, European heart journal.
[126] A. Capucci,et al. Effect of fixed-rate vs. rate-RESPONSIve pacing on exercise capacity in patients with permanent, refractory atrial fibrillation and left ventricular dysfunction treated with atrioventricular junction aBLation and bivEntricular pacing (RESPONSIBLE): a prospective, multicentre, randomized, single-blin , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[127] Kevin Vernooy,et al. Feasibility and Acute Hemodynamic Effect of Left Ventricular Septal Pacing by Transvenous Approach Through the Interventricular Septum , 2016, Circulation. Arrhythmia and electrophysiology.
[128] Claes Held,et al. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation , 2016, European heart journal.
[129] C. Hasdemir. Atrial arrhythmias in inherited arrhythmogenic disorders , 2016, Journal of arrhythmia.
[130] Andrea Mazzanti,et al. 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.
[131] Jagmeet P. Singh,et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[132] Sanjiv M. Narayan,et al. Mechanistically based mapping of human cardiac fibrillation , 2016, The Journal of physiology.
[133] Sanghamitra Mohanty,et al. Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial. , 2015, Journal of the American College of Cardiology.
[134] D. Mehta,et al. Atrial Fibrillation in Cardiac Sarcoidosis. , 2015, Journal of atrial fibrillation.
[135] H. Lambert,et al. Randomized, Controlled Trial of the Safety and Effectiveness of a Contact Force–Sensing Irrigated Catheter for Ablation of Paroxysmal Atrial Fibrillation: Results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) Study , 2015, Circulation.
[136] Akshay S. Desai,et al. Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients. , 2015, European heart journal.
[137] G. Boriani,et al. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial. , 2015, Heart rhythm.
[138] N. Freemantle,et al. The natural history of atrial fibrillation in patients with permanent pacemakers: is atrial fibrillation a progressive disease? , 2015, Journal of Interventional Cardiac Electrophysiology.
[139] G. Boriani,et al. Validation of a simple risk stratification tool for patients implanted with Cardiac Resynchronization Therapy: the VALID‐CRT risk score , 2015, European journal of heart failure.
[140] Prashanthan Sanders,et al. Indices of bipolar complex fractionated atrial electrograms correlate poorly with each other and atrial fibrillation substrate complexity. , 2015, Heart rhythm.
[141] Oliver R. Segal,et al. Is There Still a Role for Complex Fractionated Atrial Electrogram Ablation in Addition to Pulmonary Vein Isolation in Patients With Paroxysmal and Persistent Atrial Fibrillation?: Meta-Analysis of 1415 Patients , 2015, Circulation. Arrhythmia and electrophysiology.
[142] Giuseppe Boriani,et al. Management of atrial fibrillation in bradyarrhythmias , 2015, Nature Reviews Cardiology.
[143] G. Boriani,et al. Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial. , 2015, Heart rhythm.
[144] J. Healey,et al. A Systematic Review on the Progression of Paroxysmal to Persistent Atrial Fibrillation: Shedding New Light on the Effects of Catheter Ablation. , 2015, JACC. Clinical electrophysiology.
[145] Prashanthan Sanders,et al. Approaches to catheter ablation for persistent atrial fibrillation. , 2015, The New England journal of medicine.
[146] B. Pavri,et al. Impact of baseline PR interval on cardiac resynchronization therapy outcomes in patients with narrow QRS complexes: an analysis of the ReThinQ Trial , 2015, Journal of Interventional Cardiac Electrophysiology.
[147] Mårten Rosenqvist,et al. Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study , 2015, Circulation.
[148] Ziad F Issa,et al. Long‐Term Follow‐Up in AV Junction Ablation via the SVC in Patients Undergoing Concurrent Device Implantation: A Single Center Experience , 2015, Pacing and clinical electrophysiology : PACE.
[149] P. Kirchhof,et al. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis , 2014, The Lancet.
[150] C. Sticherling,et al. Comparison of Different Approaches to Atrioventricular Junction Ablation and Pacemaker Implantation in Patients with Atrial Fibrillation , 2014, Pacing and clinical electrophysiology : PACE.
[151] G. Breithardt,et al. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial , 2014, European heart journal.
[152] G. Hindricks,et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial , 2014, The Lancet.
[153] Ashok J. Shah,et al. Driver Domains in Persistent Atrial Fibrillation , 2014, Circulation.
[154] C. Combescure,et al. Management of recalled implantable cardioverter-defibrillator leads at generator replacement: a decision analysis model for Fidelis leads. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[155] A. Moss,et al. PR Interval Identifies Clinical Response in Patients With Non–Left Bundle Branch Block: A Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy Substudy , 2014, Circulation. Arrhythmia and electrophysiology.
[156] Helmut Pürerfellner,et al. Clinical classifications of atrial fibrillation poorly reflect its temporal persistence: insights from 1,195 patients continuously monitored with implantable devices. , 2014, Journal of the American College of Cardiology.
[157] Stanley Nattel,et al. Early management of atrial fibrillation to prevent cardiovascular complications. , 2014, European heart journal.
[158] Angelo Auricchio,et al. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[159] P. Ridker,et al. Predisposing Factors Associated With Development of Persistent Compared With Paroxysmal Atrial Fibrillation , 2014, Journal of the American Heart Association.
[160] G. Boriani,et al. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial , 2014, European heart journal.
[161] Niels Voigt,et al. Cellular and Molecular Electrophysiology of Atrial Fibrillation Initiation, Maintenance, and Progression , 2014, Circulation research.
[162] Dhanunjaya R. Lakkireddy,et al. Periprocedural Stroke and Bleeding Complications in Patients undergoing Catheter Ablation of Atrial Fibrillation with Different Anticoagulation Management: Results from the "COMPARE" Randomized Trial , 2014 .
[163] Michael F Swartz,et al. Dominant Frequency Increase Rate Predicts Transition from Paroxysmal to Long-Term Persistent Atrial Fibrillation , 2014, Circulation.
[164] R. Bai,et al. Pacing or Ablation: Which Is Better for Paroxysmal Atrial Fibrillation‐Related Tachycardia‐Bradycardia Syndrome? , 2014, Pacing and clinical electrophysiology : PACE.
[165] Alexander Parkhomenko,et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials , 2014, The Lancet.
[166] C. Bertrand,et al. Evaluation of Time Course and Predicting Factors of Progression of Paroxysmal or Persistent Atrial Fibrillation to Permanent Atrial Fibrillation , 2014, Pacing and clinical electrophysiology : PACE.
[167] T. Uejima,et al. Progression to the persistent form in asymptomatic paroxysmal atrial fibrillation. , 2014, Circulation journal : official journal of the Japanese Circulation Society.
[168] D. Exner,et al. Impact of Programming Strategies Aimed at Reducing Nonessential Implantable Cardioverter Defibrillator Therapies on Mortality: A Systematic Review and Meta-Analysis , 2014, Circulation. Arrhythmia and electrophysiology.
[169] M. Gasparini. Avoiding unnecessary aggressive ICD programming after MADIT-RIT and ADVANCE III trials. , 2014, Journal of the American College of Cardiology.
[170] K. Zsebo,et al. Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart FailureNovelty and Significance , 2014 .
[171] G. Boriani,et al. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry). , 2013, JACC. Heart failure.
[172] A. Proclemer,et al. Indication to cardioverter-defibrillator therapy and outcome in real world primary prevention. Data from the IRIDE [Italian registry of prophylactic implantation of defibrillators] study. , 2013, International journal of cardiology.
[173] B. Gersh,et al. Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. , 2013, European heart journal.
[174] G. Hindricks,et al. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? , 2013, European heart journal.
[175] N. Uriel,et al. Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? , 2013, Journal of the American College of Cardiology.
[176] W. Shen,et al. Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation. , 2013, Heart rhythm.
[177] Julie Redfern,et al. Screening to identify unknown atrial fibrillation , 2013, Thrombosis and Haemostasis.
[178] Mårten Rosenqvist,et al. Stepwise Screening of Atrial Fibrillation in a 75-Year-Old Population: Implications for Stroke Prevention , 2013, Circulation.
[179] V. Reddy,et al. Percutaneous Hemodynamic Support With Impella 2.5 During Scar-Related Ventricular Tachycardia Ablation (PERMIT 1) , 2013, Circulation. Arrhythmia and electrophysiology.
[180] P. Kirchhof,et al. A proposal for new clinical concepts in the management of atrial fibrillation. , 2012, American heart journal.
[181] David Keane,et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[182] M Juhani Junttila,et al. Sudden Cardiac Death Caused by Coronary Heart Disease , 2012, Circulation.
[183] G. Lip,et al. Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report , 2012, Chest.
[184] A. Goette,et al. The impact of rapid atrial pacing on ADMA and endothelial NOS. , 2012, International journal of cardiology.
[185] A. Capucci,et al. Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.
[186] Edward J Ciaccio,et al. Differences in Repeating Patterns of Complex Fractionated Left Atrial Electrograms in Longstanding Persistent Atrial Fibrillation as Compared With Paroxysmal Atrial Fibrillation , 2011, Circulation. Arrhythmia and electrophysiology.
[187] L. Stevenson,et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.
[188] M. Russo,et al. Atrial biopsy evidence of Fabry disease causing lone atrial fibrillation , 2010, Heart.
[189] J. Morgan,et al. The evaluation of pulmonary vein isolation and wide-area left atrial ablation to treat atrial fibrillation in patients with implanted permanent pacemakers: the Previously Paced Pulmonary Vein Isolation Study , 2010, Heart.
[190] Joshua J. E. Blauer,et al. Left Atrial Strain and Strain Rate in Patients With Paroxysmal and Persistent Atrial Fibrillation: Relationship to Left Atrial Structural Remodeling Detected by Delayed-Enhancement MRI , 2010, Circulation. Cardiovascular imaging.
[191] J. Seward,et al. Infiltrative cardiovascular diseases: cardiomyopathies that look alike. , 2010, Journal of the American College of Cardiology.
[192] William T. Abraham,et al. Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure , 2010, Circulation.
[193] Robby Nieuwlaat,et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. , 2010, Journal of the American College of Cardiology.
[194] Christopher E Hilker,et al. Incidence of Newly Detected Atrial Arrhythmias via Implantable Devices in Patients With a History of Thromboembolic Events , 2010, Stroke.
[195] Stephan Willems,et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial , 2010, The Lancet.
[196] V. Santinelli,et al. New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: prevalence and clinical significance. , 2009, European heart journal.
[197] Maria Grazia Bongiorni,et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). , 2009, Heart rhythm.
[198] M. Malik,et al. Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk) , 2008, European heart journal.
[199] K. Stolen,et al. A Blended Sensor Restores Chronotropic Response More Favorably than an Accelerometer Alone in Pacemaker Patients: The LIFE Study Results , 2008, Pacing and clinical electrophysiology : PACE.
[200] C. Israel,et al. The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias. , 2008, American heart journal.
[201] R. Mantovan,et al. Radiofrequency ablation of drug-refractory atrial fibrillation: an observational study comparing 'ablate and pace' with pulmonary vein isolation. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[202] P. Vardas,et al. Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover. , 2008, Journal of the American College of Cardiology.
[203] Michael J Ackerman,et al. Prevalence of early-onset atrial fibrillation in congenital long QT syndrome. , 2008, Heart rhythm.
[204] C. Antzelevitch,et al. Atrial fibrillation and Brugada syndrome. , 2008, Journal of the American College of Cardiology.
[205] Dietmar Schmitz,et al. Closed loop stimulation and accelerometer-based rate adaptation: results of the PROVIDE study. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[206] A. Goette,et al. Electrophysiological effects of angiotensin II. Part I: signal transduction and basic electrophysiological mechanisms. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[207] A. Moss,et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. , 2008, Journal of the American College of Cardiology.
[208] Jeremy N Ruskin,et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. , 2007, The New England journal of medicine.
[209] H. E. Lim,et al. Wegener’s granulomatosis with progressive conduction disturbances and atrial fibrillation , 2007, Heart.
[210] S. Priori,et al. Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. , 2007, Heart rhythm.
[211] A. Goette,et al. Cigarette smoking induces atrial fibrosis in humans via nicotine , 2007, Heart.
[212] C. Bailleul,et al. Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the 'Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)' study. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[213] P. Marino,et al. Prevention of ventricular desynchronization by permanent para-Hisian pacing after atrioventricular node ablation in chronic atrial fibrillation: a crossover, blinded, randomized study versus apical right ventricular pacing. , 2006, Journal of the American College of Cardiology.
[214] C. Tai,et al. Catheter Ablation of Atrial Fibrillation Versus Atrioventricular Junction Ablation Plus Pacing Therapy for Elderly Patients with Medically Refractory Paroxysmal Atrial Fibrillation , 2005, Journal of cardiovascular electrophysiology.
[215] H. Huikuri,et al. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. , 2005, European heart journal.
[216] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[217] D. DeMets,et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.
[218] A. Goette,et al. Nonchannel drug targets in atrial fibrillation. , 2004, Pharmacology & therapeutics.
[219] Y. Rudy,et al. Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia , 2004, Nature Medicine.
[220] J. Cleland,et al. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? , 2003, Journal of the American College of Cardiology.
[221] Neil Sulke,et al. Circadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillation. , 2003, American heart journal.
[222] C. Israel,et al. Incremental programming of atrial anti-tachycardia pacing therapies in bradycardia-indicated patients: effects on therapy efficacy and atrial tachyarrhythmia burden. , 2003, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[223] G. Breithardt,et al. Prolonged Atrial Action Potential Durations and Polymorphic Atrial Tachyarrhythmias in Patients with Long QT Syndrome , 2003, Journal of cardiovascular electrophysiology.
[224] D. Euler,et al. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. , 2003, Journal of the American College of Cardiology.
[225] B. Lüderitz,et al. Advanced Pacemaker Diagnostic Features in the Characterization of Atrial Fibrillation: Impact on Preventive Pacing Algorithms , 2003, Pacing and clinical electrophysiology : PACE.
[226] S. Hohnloser,et al. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. , 2002, Journal of the American College of Cardiology.
[227] C. Lau,et al. Automatic Mode Switching of Implantable Pacemakers: I. Principles of Instrumentation, Clinical, and Hemodynamic Considerations , 2002, Pacing and clinical electrophysiology : PACE.
[228] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[229] C W Israel,et al. Pace‐Termination and Pacing for Prevention of Atrial Tachyarrhythmias: Results from a Multicenter Study with an Implantable Device for Atrial Therapy , 2001, Journal of cardiovascular electrophysiology.
[230] G. Lip,et al. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. , 2001, European heart journal.
[231] E. Warman,et al. Efficacy of Pacing Therapies for Treating Atrial Tachyarrhythmias in Patients With Ventricular Arrhythmias Receiving a Dual-Chamber Implantable Cardioverter Defibrillator , 2001, Circulation.
[232] A. Goette,et al. Expression and activity of ectopeptidases in fibrillating human atria. , 2001, Journal of molecular and cellular cardiology.
[233] S. Connolly,et al. Circadian variation of paroxysmal atrial fibrillation , 2001 .
[234] A. Goette,et al. Increased Expression of P‐Selectin in Patients with Chronic Atrial Fibrillation , 2000, Pacing and clinical electrophysiology : PACE.
[235] A. Proclemer,et al. Safety of Pacemaker Implantation Prior to Radiofrequency Ablation of Atrioventricular Junction in a Single Session Procedure , 2000, Pacing and clinical electrophysiology : PACE.
[236] D. Casavant,et al. Permanent, direct His-bundle pacing: a novel approach to cardiac pacing in patients with normal His-Purkinje activation. , 2000, Circulation.
[237] S. Viskin,et al. Circadian variation of symptomatic paroxysmal atrial fibrillation. Data from almost 10 000 episodes. , 1999, European heart journal.
[238] J. Dartigues,et al. Scoring Method for Assessing Rate Adaptive Pacemakers: Application to Two Different Activity Sensors , 1998, Pacing and clinical electrophysiology : PACE.
[239] J. Brugada,et al. Ventricular Fibrillation and Sudden Death After Radiofrequency Catheter Ablation of the Atrioventricular Junction , 1997, Pacing and clinical electrophysiology : PACE.
[240] N Sulke,et al. Dual Sensor VVIR Mode Pacing: Is It Worth It? , 1996, Pacing and clinical electrophysiology : PACE.
[241] C. Lau,et al. Rate adaptive pacing in sick sinus syndrome: effects of pacing modes and intrinsic conduction on physiological responses, arrhythmias, symptomatology and quality of life. , 1994, European heart journal.
[242] D. Mcareavey,et al. Radiofrequency Catheter Atrioventricular Node Ablation in Patients with Permanent Cardiac Pacing Systems , 1994, Pacing and clinical electrophysiology : PACE.
[243] Jichao Zhao,et al. Transient Rotor Activity During Prolonged 3-Dimensional Phase Mapping in Human Persistent Atrial Fibrillation. , 2018, JACC. Clinical electrophysiology.
[244] James A. White,et al. Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis. , 2017, JACC. Heart failure.
[245] M. Link,et al. Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48) , 2017, Circulation. Arrhythmia and electrophysiology.
[246] G. Lip,et al. Stroke prevention in atrial fibrillation: Past, present and future. , 2017, Thrombosis and haemostasis.
[247] Volkmar Falk,et al. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.
[248] Kenneth A. Ellenbogen,et al. The Ablate and Pace Trial: A Prospective Study of Catheter Ablation of the AV Conduction System and Permanent Pacemaker Implantation for Treatment of Atrial Fibrillation , 2004, Journal of Interventional Cardiac Electrophysiology.
[249] M. Lupia,et al. Reduction of complex ventricular arrhythmias after enalapril treatment in patients with advanced stable heart failure. , 1991, Giornale italiano di cardiologia.